BP |
BP |
GO:0002504~antigen processing and presentation
of peptide or polysaccharide antigen via MHC class II |
11 |
6.23E-14 |
BP |
BP |
GO:0006955~immune response |
23 |
3.23E-08 |
BP |
BP |
GO:0019886~antigen processing and presentation
of exogenous peptide antigen via MHC class II |
12 |
8.19E-07 |
BP |
BP |
GO:0019882~antigen processing and presentation |
9 |
4.15E-05 |
BP |
BP |
GO:0031295~T cell costimulation |
9 |
6.73E-04 |
BP |
BP |
GO:0060333~interferon-gamma-mediated signaling
pathway |
8 |
0.004739 |
CC |
CC |
GO:0042613~MHC class II protein complex |
12 |
1.14E-14 |
CC |
CC |
GO:0071556~integral component of lumenal side
of endoplasmic reticulum membrane |
9 |
1.18E-07 |
CC |
CC |
GO:0030666~endocytic vesicle membrane |
11 |
3.02E-07 |
CC |
CC |
GO:0012507~ER to Golgi transport vesicle
membrane |
10 |
7.10E-07 |
CC |
CC |
GO:0030658~transport vesicle membrane |
9 |
1.26E-06 |
CC |
CC |
GO:0030669~clathrin-coated endocytic vesicle
membrane |
9 |
2.41E-06 |
CC |
CC |
GO:0032588~trans-Golgi network membrane |
10 |
5.04E-05 |
CC |
CC |
GO:0005886~plasma membrane |
66 |
1.64E-04 |
CC |
CC |
GO:0005765~lysosomal membrane |
13 |
0.005941 |
CC |
CC |
GO:0010008~endosome membrane |
11 |
0.006002 |
CC |
CC |
GO:0005887~integral component of plasma
membrane |
29 |
0.037428 |
MF |
MF |
GO:0032395~MHC class II receptor activity |
9 |
2.19E-10 |
MF |
MF |
GO:0023026~MHC class II protein complex
binding |
6 |
2.49E-04 |
MF |
MF |
GO:0042605~peptide antigen binding |
6 |
0.005142 |
KEGG |
KEGG |
hsa05166: HTLV-I infection |
16 |
1.90E-05 |
KEGG |
KEGG |
hsa05150: Staphylococcus aureus infection |
13 |
9.05E-11 |
KEGG |
KEGG |
hsa04672: Intestinal immune network for IgA production |
12 |
5.78E-10 |
KEGG |
KEGG |
hsa05310: Asthma |
10 |
7.33E-09 |
KEGG |
KEGG |
hsa05332: Graft-versus-host disease |
10 |
1.93E-08 |
KEGG |
KEGG |
hsa05330: Allograft rejection |
10 |
6.03E-08 |
KEGG |
KEGG |
hsa04940: Type I diabetes mellitus |
10 |
2.08E-07 |
KEGG |
KEGG |
hsa05321: Inflammatory bowel disease (IBD) |
11 |
5.17E-07 |
KEGG |
KEGG |
hsa05140: Leishmaniasis |
11 |
1.49E-06 |
KEGG |
KEGG |
hsa05320: Autoimmune thyroid disease |
10 |
1.59E-06 |
KEGG |
KEGG |
hsa04612: Antigen processing and presentation |
11 |
2.97E-06 |
KEGG |
KEGG |
hsa05416: Viral myocarditis |
10 |
3.73E-06 |
KEGG |
KEGG |
hsa04514: Cell adhesion molecules (CAMs) |
13 |
1.18E-05 |
KEGG |
KEGG |
hsa05323: Rheumatoid arthritis |
11 |
1.28E-05 |
KEGG |
KEGG |
hsa04145: Phagosome |
13 |
2.19E-05 |
KEGG |
KEGG |
hsa05145: Toxoplasmosis |
11 |
1.12E-04 |
KEGG |
KEGG |
hsa04662: B cell receptor signaling pathway |
9 |
3.59E-04 |
KEGG |
KEGG |
hsa05322: Systemic lupus erythematosus |
11 |
7.23E-04 |
KEGG |
KEGG |
hsa05152: Tuberculosis |
12 |
0.001189 |
KEGG |
KEGG |
hsa05168: Herpes simplex infection |
12 |
0.001656 |
KEGG |
KEGG |
hsa05169: Epstein-Barr virus infection |
10 |
0.003051 |
KEGG |
KEGG |
hsa05164: Influenza A |
11 |
0.007827 |
KEGG |
KEGG |
hsa04640: Hematopoietic cell lineage |
8 |
0.024346 |